{"id": "1340981557323046913", "creation": 1608549892.0, "user_id": "621185967", "social_network": "twitter", "nsfw": false, "request": ["b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc"], "metrics": {"b26b9dbc-1c5a-4cd3-a3a6-c2f5a51ad0fc": {"retweet_count": 0, "reply_count": 0, "like_count": 1, "quote_count": 0}}, "quoted": "1340970321004904449", "text": "\u201c#China has begun work on a facility to manufacture its first #COVID19 #vaccine candidate that uses messenger RNA (mRNA) technology... The candidate, known as ARCoV or ARCoVax, has entered a Phase 1b clinical trial in October after a Phase 1 trial that started in June...\u201d\ud83e\udd14 https://t.co/8YfBKc1Jxv", "first_save": 1634559108.199414, "hashtags": ["#CHINA", "#COVID19", "#VACCINE"]}